'Fine-tuning' blood flow to the exercising muscle with advancing age: An update

Experimental Physiology

Volumn 100, Issue 6, 2015, Pages 589-602

  Wray, D Walter ^a,b,c   Richardson, Russell S ^a,b,c  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; ENDOTHELIN 1; NITRIC OXIDE; ALPHA ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; AGING; ARTERY BLOOD FLOW; BRACHIAL ARTERY; DYNAMIC EXERCISE; EXERCISE; HAND GRIP; HUMAN; IN VIVO STUDY; MUSCLE BLOOD FLOW; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SKELETAL MUSCLE; SYMPATHETIC TONE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; ADAPTATION; AGE; BLOOD FLOW; INNERVATION; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; AGE FACTORS; AGING; ANGIOTENSIN II; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXERCISE; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RECEPTORS, ADRENERGIC, ALPHA; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 84930575645     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085076     Document Type: Review

References (80)

1. Andersen P & Saltin B (1985). Maximal perfusion of skeletal muscle in man. J Physiol 366, 233-249.
2. Arai H, Hori S, Aramori I, Ohkubo H & Nakanishi S (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730-732.
3. Barrett-O'Keefe Z, Ives SJ, Trinity JD, Morgan G, Rossman MJ, Donato AJ, Runnels S, Morgan DE, Gmelch BS, Bledsoe AD, Richardson RS & Wray DW (2015). Endothelin-A-mediated vasoconstriction during exercise with advancing age. J Gerontol A Biol Sci Med Sci 70, 554-565.
4. Barrett-O'Keefe Z, Witman MA, McDaniel J, Fjeldstad AS, Trinity JD, Ives SJ, Conklin JD, Reese V, Runnels S, Morgan DE, Sander M, Richardson RS & Wray DW (2013). Angiotensin II potentiates α-adrenergic vasoconstriction in the elderly. Clin Sci 124, 413-422.
5. Beere PA, Russell SD, Morey MC, Kitzman DW & Higginbotham MB (1999). Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men. Circulation 100, 1085-1094.
6. 1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes. Am J Physiol Heart Circ Physiol 293, H2281-H2288.
7. Brothers RM, Haslund ML, Wray DW, Raven PB & Sander M (2006). Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle. J Physiol 577, 727-737.
8. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J & Zelis R (1994). Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest 93, 684-691.
9. Clifford PS, Kluess HA, Hamann JJ, Buckwalter JB & Jasperse JL (2006). Mechanical compression elicits vasodilatation in rat skeletal muscle feed arteries. J Physiol 572, 561-567.
10. Crecelius AR, Kirby BS, Voyles WF & Dinenno FA (2010). Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults. Am J Physiol Heart Circ Physiol 299, H1633-H1641.
11. Davy KP, Seals DR & Tanaka H (1998). Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 32, 298-304.
12. Degens H (1998). Age-related changes in the microcirculation of skeletal muscle. Adv Exp Med Biol 454, 343-348.
13. Dinenno FA, Jones PP, Seals DR & Tanaka H (1999). Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation 100, 164-170.
14. Dinenno FA & Joyner MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553, 281-292.
15. Dinenno FA, Masuki S & Joyner MJ (2005). Impaired modulation of sympathetic α-adrenergic vasoconstriction in contracting forearm muscle of ageing men. J Physiol 567, 311-321.
16. Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K & Seals DR (2009). Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 297, H425-H432.
17. Duggan J, Kilfeather S, O'Brien E, O'Malley K & Nussberger J (1992). Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density. Am J Hypertens 5, 687-693.
18. Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S & Takeshita A (1994). Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 90, 2886-2890.
19. Fadel PJ, Wang Z, Watanabe H, Arbique D, Vongpatanasin W & Thomas GD (2004). Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy. J Physiol 561, 893-901.
20. G-nitro-l-arginine methyl ester in humans. J Physiol 531, 257-264.
21. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
22. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR & Quyyumi AA (1994). Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 90, 2853-2858.
23. Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Münter K, Müller SP, Shaw S & Barton M (2001). Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun 280, 908-913.
24. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB & Bahou WF (1994). Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158, 485-494.
25. Gordon RD, Küchel O, Liddle GW & Island DP (1967). Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46, 599-605.
26. Green DJ, Bilsborough W, Naylor LH, Reed C, Wright J, O'Driscoll G & Walsh JH (2005). Comparison of forearm blood flow responses to incremental handgrip and cycle ergometer exercise: relative contribution of nitric oxide. J Physiol 562, 617-628.
27. Heinonen I, Saltin B, Kemppainen J, Sipilä HT, Oikonen V, Nuutila P, Knuuti J, Kalliokoski K & Hellsten Y (2011). Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition. Am J Physiol Heart Circ Physiol 300, H1510-H1517.
28. Ishihata A, Katano Y, Morinobu S & Endoh M (1991). Influence of aging on the contractile response to endothelin of rat thoracic aorta. Eur J Pharmacol 200, 199-201.
29. Kingwell BA (2000). Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 14, 1685-1696.
30. Koch DW, Leuenberger UA & Proctor DN (2003). Augmented leg vasoconstriction in dynamically exercising older men during acute sympathetic stimulation. J Physiol 551, 337-344.
31. Kourembanas S, Marsden PA, McQuillan LP & Faller DV (1991). Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88, 1054-1057.
32. Krum H, Viskoper RJ, Lacourciere Y, Budde M & Charlon V (1998). The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 338, 784-790.
33. Lakatta EG (1990). Changes in cardiovascular function with aging. Eur Heart J 11 (Suppl C), 22-29.
34. Laughlin MH & Korzick DH (2001). Vascular smooth muscle: integrator of vasoactive signals during exercise hyperemia. Med Sci Sports Exerc 33, 81-91.
35. 2 max. Am J Physiol Heart Circ Physiol 286, H1565-H1572.
36. Lawrenson L, Poole JG, Kim J, Brown C, Patel P & Richardson RS (2003). Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol 285, H1023-H1031.
37. Lüscher TF & Barton M (2000). Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102, 2434-2440.
38. Lyons D, Webster J & Benjamin N (1995). Angiotensin II. Adrenergic sympathetic constrictor action in humans. Circulation 91, 1457-1460.
39. Macarthur H, Warner TD, Wood EG, Corder R & Vane JR (1994). Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 200, 395-400.
40. McEniery CM, Wilkinson IB, Jenkins DG & Webb DJ (2002). Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 40, 202-206.
41. Maeda S, Miyauchi T, Goto K & Matsuda M (1997). Differences in the change in the time course of plasma endothelin-1 and endothelin-3 levels after exercise in humans. The response to exercise of endothelin-3 is more rapid than that of endothelin-1. Life Sci 61, 419-425.
42. Malek A & Izumo S (1992). Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J Physiol Cell Physiol 263, C389-C396.
43. Merkus D, Houweling B, Mirza A, Boomsma F, vanden Meiracker AH & Duncker DJ (2003). Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59, 745-754.
44. Michel T & Vanhoutte PM (2010). Cellular signaling and NO production. Pflugers Arch 459, 807-816.
45. Mortensen SP, Nyberg M, Winding K & Saltin B (2012). Lifelong physical activity preserves functional sympatholysis and purinergic signalling in the ageing human leg. J Physiol 590, 6227-6236.
46. Ng AV, Callister R, Johnson DG & Seals DR (1993). Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21, 498-503.
47. Palmer RM, Ferrige AG & Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
48. Parker BA, Smithmyer SL, Pelberg JA, Mishkin AD & Proctor DN (2008). Sex-specific influence of aging on exercising leg blood flow. J Appl Physiol 104, 655-664.
49. Poole JG, Lawrenson L, Kim J, Brown C & Richardson RS (2003). Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol 284, H1251-H1259.
50. Proctor DN & Moore DJ (2012). Lifelong physical activity and blood flow to active muscles: sufficient supply to meet the demand. J Physiol 590, 5927-5928.
51. Proctor DN & Newcomer SC (2006). Is there a difference in vascular reactivity of the arms and legs? Med Sci Sports Exerc 38, 1819-1828.
52. Proctor DN & Parker BA (2006). Vasodilation and vascular control in contracting muscle of the aging human. Microcirculation 13, 315-327.
53. Proctor DN, Shen PH, Dietz NM, Eickhoff TJ, Lawler LA, Ebersold EJ, Loeffler DL & Joyner MJ (1998). Reduced leg blood flow during dynamic exercise in older endurance-trained men. J Appl Physiol 85, 68-75.
54. Rådegran G & Saltin B (1999). Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol Heart Circ Physiol 276, H1951-H1960.
55. Remensnyder JP, Mitchell JH & Sarnoff SJ (1962). Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res 11, 370-380.
56. 2 extraction compromised? J Appl Physiol 75, 1911-1916.
57. Rubanyi GM, Romero JC & Vanhoutte PM (1986). Flow-induced release of endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250, H1145-H1149.
58. Schrage WG, Eisenach JH & Joyner MJ (2007). Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J Physiol 579, 227-236.
59. Schrage WG, Joyner MJ & Dinenno FA (2004). Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J Physiol 557, 599-611.
60. Shoemaker JK, Halliwill JR, Hughson RL & Joyner MJ (1997). Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol Heart Circ Physiol 273, H2388-H2395.
61. Siebers MJ, Goodfriend TL, Ball D & Elliott ME (1990). Analysis of angiotensin II binding to human platelets: differences in young and old subjects. J Gerontol 45, B42-B47.
62. Smith EG, Voyles WF, Kirby BS, Markwald RR & Dinenno FA (2007). Ageing and leg postjunctional α-adrenergic vasoconstrictor responsiveness in healthy men. J Physiol 582, 63-71.
63. Smith SA, Mitchell JH & Garry MG (2006). The mammalian exercise pressor reflex in health and disease. Exp Physiol 91, 89-102.
64. Stebbins CL & Symons JD (1995). Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine. J Appl Physiol 78, 185-190.
65. Sundlöf G & Wallin BG (1978). Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 274, 621-637.
66. Symons JD & Stebbins CL (1996). Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J Cardiovasc Pharmacol 28, 223-231.
67. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A & Salvetti A (2001). Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279.
68. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I & Salvetti A (1995). Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91, 1981-1987.
69. Thijssen DH, Rongen GA, vanDijk A, Smits P & Hopman MT (2007). Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. J Appl Physiol 103, 852-857.
70. Thomas GD & Segal SS (2004). Neural control of muscle blood flow during exercise. J Appl Physiol 97, 731-738.
71. Tidgren B, Hjemdahl P, Theodorsson E & Nussberger J (1991). Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol 70, 2279-2286.
72. Trinity JD, Wray DW, Witman MA, Layec G, Barrett-O'Keefe Z, Ives SJ, Conklin JD, Reese V & Richardson RS (2013). Contribution of nitric oxide to brachial artery vasodilation during progressive handgrip exercise in the elderly. Am J Physiol Regul Integr Comp Physiol 305, R893-R899.
73. Tschakovsky ME & Joyner MJ (2008). Nitric oxide and muscle blood flow in exercise. Appl Physiol Nutr Metab 33, 151-161.
74. VanGuilder GP, Westby CM, Greiner JJ, Stauffer BL & DeSouza CA (2007). Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50, 403-409.
75. Wray DW, Fadel PJ, Smith ML, Raven P & Sander M (2004). Inhibition of alpha-adrenergic vasoconstriction in exercising human thigh muscles. J Physiol 555, 545-563.
76. Wray DW, Nishiyama SK, Donato AJ, Sander M, Wagner PD & Richardson RS (2007). Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans. Am J Physiol Heart Circ Physiol 293, H2550-H2556.
77. Wray DW, Nishiyama SK, Harris RA & Richardson RS (2008). Angiotensin II in the elderly: impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics. Hypertension 51, 1611-1616.
78. 1-adrenergic vasoconstriction in the regulation of skeletal muscle blood flow with advancing age. Am J Physiol Heart Circ Physiol 296, H497-H504.
79. Wray DW, Witman MA, Ives SJ, McDaniel J, Fjeldstad AS, Trinity JD, Conklin JD, Supiano MA & Richardson RS (2011). Progressive handgrip exercise: evidence of nitric oxide-dependent vasodilation and blood flow regulation in humans. Am J Physiol Heart Circ Physiol 300, H1101-H1107.
80. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K & Masaki T (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.